Anti-Proliferative Effects of Rutin on OLETF Rat Vascular Smooth Muscle Cells Stimulated by Glucose Variability. 2016

Sung Hoon Yu, and Jae Myung Yu, and Hyung Joon Yoo, and Seong Jin Lee, and Dong Hyun Kang, and Young Jung Cho, and Doo Man Kim
Division of Endocrinology and Metabolism, Hallym University College of Medicine, Seoul, Korea.

OBJECTIVE Proliferation of vascular smooth muscle cells (VSMCs) plays a crucial role in atherosclerosis. Rutin is a major representative of the flavonol subclass of flavonoids and has various pharmacological activities. Currently, data are lacking regarding its effects on VSMC proliferation induced by intermittent hyperglycemia. Here, we demonstrate the effects of rutin on VSMC proliferation and migration according to fluctuating glucose levels. METHODS Primary cultures of male Otsuka Long-Evans Tokushima Fatty (OLETF) rat VSMCs were obtained from enzymatically dissociated rat thoracic aortas. VSMCs were incubated for 72 h with alternating normal (5.5 mmol/L) and high (25.0 mmol/L) glucose media every 12 h. Proliferation and migration of VSMCs, the proliferative molecular pathway [including p44/42 mitogen-activated protein kinases (MAPK), mitogen-activated protein kinase kinase 1/2 (MEK1/2), p38 MAPK, phosphoinositide 3-kinase (PI3K), c-Jun N-terminal protein kinase (JNK), nuclear factor kappa B (NF-κB), and Akt], the migratory pathway (big MAPK 1, BMK1), reactive oxygen species (ROS), and apoptotic pathway were analyzed. RESULTS We found enhanced proliferation and migration of VSMCs when cells were incubated in intermittent high glucose conditions, compared to normal glucose. These effects were lowered upon rutin treatment. Intermittent treatment with high glucose for 72 h increased the expression of phospho-p44/42 MAPK (extracellular signal regulated kinase 1/2, ERK1/2), phospho-MEK1/2, phospho-PI3K, phospho-NF-κB, phospho-BMK1, and ROS, compared to treatment with normal glucose. These effects were suppressed by rutin. Phospho-p38 MAPK, phospho-Akt, JNK, and apoptotic pathways [B-cell lymphoma (Bcl)-xL, Bcl-2, phospho-Bad, and caspase-3] were not affected by fluctuations in glucose levels. CONCLUSIONS Fluctuating glucose levels increased proliferation and migration of OLETF rat VSMCs via MAPK (ERK1/2), BMK1, PI3K, and NF-κB pathways. These effects were inhibited by the antioxidant rutin.

UI MeSH Term Description Entries
D008297 Male Males
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012431 Rutin A flavonol glycoside found in many plants, including BUCKWHEAT; TOBACCO; FORSYTHIA; HYDRANGEA; VIOLA, etc. It has been used therapeutically to decrease capillary fragility. 3-Rhamnosyl-Glucosyl Quercetin,Quercetin-3-Rutinoside,Rutoside,Quercetin 3 Rutinoside,Quercetin, 3-Rhamnosyl-Glucosyl
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D047428 Protein Kinase Inhibitors Agents that inhibit PROTEIN KINASES. Protein Kinase Inhibitor,Inhibitor, Protein Kinase,Inhibitors, Protein Kinase,Kinase Inhibitor, Protein,Kinase Inhibitors, Protein

Related Publications

Sung Hoon Yu, and Jae Myung Yu, and Hyung Joon Yoo, and Seong Jin Lee, and Dong Hyun Kang, and Young Jung Cho, and Doo Man Kim
November 2008, Biological & pharmaceutical bulletin,
Sung Hoon Yu, and Jae Myung Yu, and Hyung Joon Yoo, and Seong Jin Lee, and Dong Hyun Kang, and Young Jung Cho, and Doo Man Kim
August 2004, Biochemical and biophysical research communications,
Sung Hoon Yu, and Jae Myung Yu, and Hyung Joon Yoo, and Seong Jin Lee, and Dong Hyun Kang, and Young Jung Cho, and Doo Man Kim
May 2019, Journal of ethnopharmacology,
Sung Hoon Yu, and Jae Myung Yu, and Hyung Joon Yoo, and Seong Jin Lee, and Dong Hyun Kang, and Young Jung Cho, and Doo Man Kim
June 2004, Journal of Asian natural products research,
Sung Hoon Yu, and Jae Myung Yu, and Hyung Joon Yoo, and Seong Jin Lee, and Dong Hyun Kang, and Young Jung Cho, and Doo Man Kim
July 2024, Phytomedicine : international journal of phytotherapy and phytopharmacology,
Sung Hoon Yu, and Jae Myung Yu, and Hyung Joon Yoo, and Seong Jin Lee, and Dong Hyun Kang, and Young Jung Cho, and Doo Man Kim
August 2001, American journal of physiology. Heart and circulatory physiology,
Sung Hoon Yu, and Jae Myung Yu, and Hyung Joon Yoo, and Seong Jin Lee, and Dong Hyun Kang, and Young Jung Cho, and Doo Man Kim
December 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
Sung Hoon Yu, and Jae Myung Yu, and Hyung Joon Yoo, and Seong Jin Lee, and Dong Hyun Kang, and Young Jung Cho, and Doo Man Kim
January 1992, Japanese journal of pharmacology,
Sung Hoon Yu, and Jae Myung Yu, and Hyung Joon Yoo, and Seong Jin Lee, and Dong Hyun Kang, and Young Jung Cho, and Doo Man Kim
September 2010, Bioorganic & medicinal chemistry letters,
Sung Hoon Yu, and Jae Myung Yu, and Hyung Joon Yoo, and Seong Jin Lee, and Dong Hyun Kang, and Young Jung Cho, and Doo Man Kim
June 2007, American journal of physiology. Heart and circulatory physiology,
Copied contents to your clipboard!